• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CYP 同工酶对药物代谢的特异性:基于共有特征假设的分析。

CYP isoform specificity toward drug metabolism: analysis using common feature hypothesis.

机构信息

Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, S. A. S Nagar, Mohali 160 062, India.

出版信息

J Mol Model. 2012 Feb;18(2):709-20. doi: 10.1007/s00894-011-1105-5. Epub 2011 May 12.

DOI:10.1007/s00894-011-1105-5
PMID:21562823
Abstract

Three dimensional pharmacophoric maps were generated for each isoforms of CYP2C9, CYP2D6 and CYP3A4 separately using independent training sets consist of highly potent substrates (seven substrates for each isoform). HipHop module of CATALYST software was used in the generation of pharmacophore models. The best pharmacophore model was chosen out of the several models on the basis of (i) highest ranking score, (ii) better fit value among training set, (iii) capability to screen substrates from data set and (iv) efficiency to identify the isoform specificity. The individual pharmacophore models (CYP2C9-hypo1, CYP2D6-hypo1 and CYP3A4-hypo1) are characterized by the pharmacophoric features XZDH, RPZH and XYZHH for the CYP2C9, CYP2D6 and CYP3A4 respectively. Each of the chosen models was validated by using data sets of CYP substrates. This comparative study of CYP substrates demonstrates the importance of acidic character along with HBD and HBAl features for CYP2C9, basic character with ring aromatic features for CYP2D6 and hydrophobic features for CYP3A4. Acidity, basicity and hydrophobicity features arising from the functional groups of the substrates are also responsible for demonstrating CYP isoform specificity. Hence, these chemical features are incorporated in the decision tree along with pharmacophore maps. Finally, a decision tree based on chemical features and pharmacophore features was generated to identify the isoform specificity of novel query molecule toward the three isoforms.

摘要

分别为 CYP2C9、CYP2D6 和 CYP3A4 的每个同工型单独生成三维药效团图谱,使用由高活性底物组成的独立训练集(每个同工型有七种底物)。CATALYST 软件的 HipHop 模块用于药效团模型的生成。在几个模型中,根据以下标准选择最佳药效团模型:(i) 最高排名得分,(ii) 在训练集中更好的拟合值,(iii) 从数据集筛选底物的能力,以及 (iv) 识别同工型特异性的效率。单个药效团模型(CYP2C9-hypo1、CYP2D6-hypo1 和 CYP3A4-hypo1)的特征是 CYP2C9、CYP2D6 和 CYP3A4 分别具有 XZDH、RPZH 和 XYZHH 药效团特征。所选的每个模型都通过 CYP 底物数据集进行验证。对 CYP 底物的比较研究表明,对于 CYP2C9,酸性特征以及氢键供体 (HBD) 和氢键接受体 (HBAl) 特征很重要;对于 CYP2D6,碱性特征以及带有芳香环的特征很重要;对于 CYP3A4,疏水性特征很重要。底物的官能团产生的酸性、碱性和疏水性特征也有助于证明 CYP 同工型特异性。因此,这些化学特征与药效团图谱一起被纳入决策树。最后,生成了一个基于化学特征和药效团特征的决策树,以确定新型查询分子对三种同工型的同工型特异性。

相似文献

1
CYP isoform specificity toward drug metabolism: analysis using common feature hypothesis.CYP 同工酶对药物代谢的特异性:基于共有特征假设的分析。
J Mol Model. 2012 Feb;18(2):709-20. doi: 10.1007/s00894-011-1105-5. Epub 2011 May 12.
2
Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates.细胞色素P-450 3A4底物的三维定量构效关系分析
J Pharmacol Exp Ther. 1999 Oct;291(1):424-33.
3
Comparison of metabolic soft spot predictions of CYP3A4, CYP2C9 and CYP2D6 substrates using MetaSite and StarDrop.使用MetaSite和StarDrop对CYP3A4、CYP2C9和CYP2D6底物的代谢软点预测进行比较。
Comb Chem High Throughput Screen. 2011 Nov;14(9):811-23. doi: 10.2174/138620711796957170.
4
In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.积雪草中多种活性成分和提取物对三种主要人细胞色素 P450 酶的体外调节作用。
J Ethnopharmacol. 2010 Jul 20;130(2):275-83. doi: 10.1016/j.jep.2010.05.002. Epub 2010 May 8.
5
Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4.人肝CYP同工酶对2,5-双(三氟甲基)-7-苄氧基-4-三氟甲基香豆素的代谢:对CYP3A4选择性的证据
Xenobiotica. 2001 Apr;31(4):187-204. doi: 10.1080/00498250110043526.
6
Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule.预测负责代谢药物分子的细胞色素P450同工酶。
BMC Pharmacol. 2010 Jul 16;10:8. doi: 10.1186/1471-2210-10-8.
7
Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and Metabolism.用于监测细胞色素P450-P450相互作用及代谢的固定化细胞色素P450
Drug Metab Dispos. 2016 May;44(5):741-9. doi: 10.1124/dmd.115.067637. Epub 2016 Mar 9.
8
Importance of hydrophobic parameters in identifying appropriate pose of CYP substrates in cytochromes.疏水性参数在鉴定细胞色素中 CYP 底物合适构象中的重要性。
Eur J Med Chem. 2014 Jan;71:15-23. doi: 10.1016/j.ejmech.2013.10.023. Epub 2013 Oct 28.
9
Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms.黄芪和地黄对糖尿病足溃疡中药配方模型 CYP1A2、CYP2C9、CYP2D6、CYP2E1 和 CYP3A4 探针底物在人肝微粒体中的代谢及特定 CYP 同工酶的影响。
Phytomedicine. 2012 Apr 15;19(6):535-44. doi: 10.1016/j.phymed.2011.12.005. Epub 2012 Jan 18.
10
Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers.使用组合分类器对细胞色素 P450 抑制剂和非抑制剂进行分类。
J Chem Inf Model. 2011 May 23;51(5):996-1011. doi: 10.1021/ci200028n. Epub 2011 Apr 14.

引用本文的文献

1
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication and Decreases Viral Titers and Disease Progression in Syrian Hamsters.美国食品和药物管理局批准的药物考比司他与瑞德西韦协同抑制 SARS-CoV-2 复制,降低叙利亚仓鼠的病毒滴度和疾病进展。
mBio. 2022 Apr 26;13(2):e0370521. doi: 10.1128/mbio.03705-21. Epub 2022 Mar 1.

本文引用的文献

1
Shape- and chemical feature-based 3D-pharmacophore model generation and virtual screening: identification of potential leads for P. falciparum DHFR enzyme inhibition.基于形状和化学特征的 3D 药效团模型生成和虚拟筛选:鉴定潜在的恶性疟原虫 DHFR 酶抑制剂先导化合物。
Chem Biol Drug Des. 2010 Jan;75(1):115-26. doi: 10.1111/j.1747-0285.2009.00908.x. Epub 2009 Nov 5.
2
Theoretical characterization of substrate access/exit channels in the human cytochrome P450 3A4 enzyme: involvement of phenylalanine residues in the gating mechanism.人细胞色素 P450 3A4 酶中底物进入/退出通道的理论特征:苯丙氨酸残基在门控机制中的作用。
J Phys Chem B. 2009 Oct 1;113(39):13018-25. doi: 10.1021/jp810386z.
3
CypScore: Quantitative prediction of reactivity toward cytochromes P450 based on semiempirical molecular orbital theory.
CypScore:基于半经验分子轨道理论对细胞色素P450反应性的定量预测。
ChemMedChem. 2009 Apr;4(4):657-69. doi: 10.1002/cmdc.200800384.
4
Minimum requirements of hydrophobic and hydrophilic features in cationic peptide antibiotics (CPAs): pharmacophore generation and validation with cationic steroid antibiotics (CSAs).阳离子肽抗生素(CPA)中疏水和亲水特性的最低要求:药效团的生成及与阳离子甾体抗生素(CSA)的验证。
J Mol Model. 2008 Apr;14(4):265-78. doi: 10.1007/s00894-008-0268-1. Epub 2008 Feb 13.
5
Evaluation of descriptors and classification schemes to predict cytochrome substrates in terms of chemical information.根据化学信息评估描述符和分类方案以预测细胞色素底物。
J Comput Aided Mol Des. 2008 Jun-Jul;22(6-7):385-92. doi: 10.1007/s10822-008-9176-9. Epub 2008 Jan 23.
6
The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP) predicts in vivo metabolic inhibition.细胞色素P450 3A4(CYP3A4)抑制对厄洛替尼药代动力学的影响:基于计算机的模拟(SimCYP)预测体内代谢抑制作用。
Eur J Clin Pharmacol. 2008 Jan;64(1):31-41. doi: 10.1007/s00228-007-0396-z. Epub 2007 Nov 14.
7
In vitro prediction and in vivo verification of enantioselective human tofisopam metabolite profiles.对映选择性人体托非索泮代谢物谱的体外预测与体内验证
Drug Metab Dispos. 2007 Oct;35(10):1894-902. doi: 10.1124/dmd.107.015875. Epub 2007 Jul 23.
8
Ligand-based models for the isoform specificity of cytochrome P450 3A4, 2D6, and 2C9 substrates.基于配体的细胞色素P450 3A4、2D6和2C9底物亚型特异性模型。
J Chem Inf Model. 2007 Jul-Aug;47(4):1688-701. doi: 10.1021/ci700010t. Epub 2007 Jul 3.
9
Applying mechanisms of chemical toxicity to predict drug safety.应用化学毒性机制预测药物安全性。
Chem Res Toxicol. 2007 Mar;20(3):344-69. doi: 10.1021/tx600260a. Epub 2007 Feb 16.
10
Reaction site mapping of xenobiotic biotransformations.外源生物转化的反应位点图谱
J Chem Inf Model. 2007 Mar-Apr;47(2):583-90. doi: 10.1021/ci600376q. Epub 2007 Feb 16.